Management of invasive bladder cancer in patients who are not candidates for or decline cystectomy

by Balar, Arjun, Bajorin, Dean F., Milowsky, Matthew I.
Published 2011

Clinical states model for biomarkers in bladder cancer

by Apolo, Andrea B, Milowsky, Matthew, Bajorin, Dean F.
Published 2009

Novel strategies for treating relapsed/refractory urothelial carcinoma

by Iyer, Gopa, Milowsky, Matthew I, Bajorin, Dean F
Published 2010

Tracking the Workforce: The American Society of Clinical Oncology Workforce Information System

by Kirkwood, M. Kelsey, Kosty, Michael P., Bajorin, Dean F., Bruinooge, Suanna S., Goldstein, Michael A.
Published 2013

Clinical Value of Fluorine-18 2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography/Computed Tomography in Bladder Cancer

by Apolo, Andrea B., Riches, Jamie, Schöder, Heiko, Akin, Oguz, Trout, Alisa, Milowsky, Matthew I., Bajorin, Dean F.
Published 2010

Who Does Not Receive Treatment for Cancer?

by Ward, Marcia M., Ullrich, Fred, Matthews, Kevin, Rushton, Gerard, Goldstein, Michael A., Bajorin, Dean F., Hanley, Amy, Lynch, Charles F.
Published 2013

The High Incidence of Vascular Thromboembolic Events in Advanced Urothelial Cancer Treated with Platinum Chemotherapy Agents

by Tully, Christopher M., Apolo, Andrea B., Zabor, Emily C., Regazzi, Ashley M., Ostrovnaya, Irina, Rosenberg, Jonathan E., Bajorin, Dean F.
Published in Cancer (2015)

Rates of Teratoma and Viable Cancer at Post-Chemotherapy Retroperitoneal Lymph Node Dissection after Induction Chemotherapy for Good Risk Non-Seminomatous Germ Cell Tumors

by Kundu, Shilajit D., Feldman, Darren R., Carver, Brett S., Gupta, Amit, Bosl, George J., Motzer, Robert J., Bajorin, Dean F., Sheinfeld, Joel
Published in J Urol (2014)

Improved 5-factor prognostic classification of patients receiving salvage systemic therapy for advanced urothelial carcinoma

by Sonpavde, Guru, Pond, Gregory R., Rosenberg, Jonathan E., Bajorin, Dean F., Choueiri, Toni K., Necchi, Andrea, Di Lorenzo, Giuseppe, Bellmunt, Joaquim
Published in J Urol (2015)

Clinical Outcome of Patients with Fibrosis/Necrosis at Post-Chemotherapy Retroperitoneal Lymph Node Dissection for Advanced Germ Cell Tumors

by Mano, Roy, Becerra, Maria F., Carver, Brett S., Bosl, George J., Motzer, Robert J., Bajorin, Dean F., Feldman, Darren R., Sheinfeld, Joel
Published in J Urol (2016)

Surgical Management of Patients with Advanced Germ Cell Tumors Following Salvage Chemotherapy: Memorial Sloan Kettering Cancer Center (MSKCC) Experience.

by Miller, Mariam Imnadze, Feifer, Andrew, Feldman, Darren R., Carver, Brett S., Bosl, George J., Motzer, Robert J., Bajorin, Dean F., Sheinfeld, Joel
Published in Urology (2018)

Final Results of Sequential Doxorubicin Plus Gemcitabine and Ifosfamide, Paclitaxel, and Cisplatin Chemotherapy in Patients With Metastatic or Locally Advanced Transitional Cell Ca...

by Milowsky, Matthew I., Nanus, David M., Maluf, Fernando C., Mironov, Svetlana, Shi, Weiji, Iasonos, Alexia, Riches, Jamie, Regazzi, Ashley, Bajorin, Dean F.
Published in J Clin Oncol (2009)

Barriers to a Career Focus in Cancer Prevention: A Report and Initial Recommendations From the American Society of Clinical Oncology Cancer Prevention Workforce Pipeline Work Group

by Fabian, Carol J., Meyskens, Frank L., Bajorin, Dean F., George, Thomas J., Jeter, Joanne M., Khan, Shakila, Tyne, Courtney A., William, William N.
Published in J Clin Oncol (2016)

Global Cancer Transcriptome Quantifies Repeat Element Polarization between Immunotherapy Responsive and T Cell Suppressive Classes

by Solovyov, Alexander, Vabret, Nicolas, Arora, Kshitij S., Snyder, Alexandra, Funt, Samuel A., Bajorin, Dean F., Rosenberg, Jonathan E., Bhardwaj, Nina, Ting, David T., Greenbaum, Benjamin D.
Published in Cell Rep (2018)

The histone deacetylase inhibitor belinostat (PXD101) suppresses bladder cancer cell growth in vitro and in vivo

by Buckley, Michael T, Yoon, Joanne, Yee, Herman, Chiriboga, Luis, Liebes, Leonard, Ara, Gulshan, Qian, Xiaozhong, Bajorin, Dean F, Sun, Tung-Tien, Wu, Xue-Ru, Osman, Iman
Published 2007

Impact of Teratoma on the Cumulative Incidence of Disease-Related Death in Patients With Advanced Germ Cell Tumors

by Funt, Samuel A., Patil, Sujata, Feldman, Darren R., Motzer, Robert J., Bajorin, Dean F., Sheinfeld, Joel, Tickoo, Satish K., Reuter, Victor E., Bosl, George J.
Published in J Clin Oncol (2019)

CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma

by Sharma, Padmanee, Shen, Yu, Wen, Sijin, Yamada, Sachiko, Jungbluth, Achim A., Gnjatic, Sacha, Bajorin, Dean F., Reuter, Victor E., Herr, Harry, Old, Lloyd J., Sato, Eiichi
Published 2007

A Role for Neoadjuvant Gemcitabine Plus Cisplatin in Muscle-Invasive Urothelial Carcinoma of the Bladder: A Retrospective Experience

by Dash, Atreya, Pettus, Joseph A., Herr, Harry W., Bochner, Bernard H., Dalbagni, Guido, Donat, S. Machele, Russo, Paul, Boyle, Mary G., Milowsky, Matthew I., Bajorin, Dean F.
Published 2008

Prognostic Model for Predicting Survival of Patients With Metastatic Urothelial Cancer Treated With Cisplatin-Based Chemotherapy

by Apolo, Andrea B., Ostrovnaya, Irina, Halabi, Susan, Iasonos, Alexia, Philips, George K., Rosenberg, Jonathan E., Riches, Jamie, Small, Eric J., Milowsky, Matthew I., Bajorin, Dean F.
Published 2013

TI-CE High-Dose Chemotherapy for Patients With Previously Treated Germ Cell Tumors: Results and Prognostic Factor Analysis

by Feldman, Darren R., Sheinfeld, Joel, Bajorin, Dean F., Fischer, Patricia, Turkula, Stefan, Ishill, Nicole, Patil, Sujata, Bains, Manjit, Reich, Lilian M., Bosl, George J., Motzer, Robert J.
Published 2010